Trading in Novo Nordisk shares by board
Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 5 August 2022 — This document discloses the data of the transaction(s) made in Novo Nordisk ...
Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 5 August 2022 — This document discloses the data of the transaction(s) made in Novo Nordisk ...
Bagsværd, Denmark, 25 July 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...
Bagsværd, Denmark, 20 June 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...
Bagsværd, Denmark, 23 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...
Bagsværd, Denmark, 16 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...
Bagsværd, Denmark, 11 May 2022 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in ...
Novo Nordisk – major shareholder announcement Bagsværd, Denmark, 6 May 2022 – Novo Nordisk today announced that the company has been notified by BlackRock, Inc. (Blackrock) that Blackrock as of 29 ...
Bagsværd, Denmark, 2 May 2022 – Novo Nordisk today announced that the company has been notified by BlackRock, Inc. (Blackrock) as follows: Blackrock holds as of 25 April 2022 B shares ...
Financial report for the period 1 January 2022 to 31 March 2022 ...
Bagsværd, Denmark, 11 April 2022 – On 2 February 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...